From Yahoo Finance: 2025-06-15 05:26:00

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) was mentioned as one of the 16 stocks Jim Cramer recently discussed. Cramer expressed positivity towards the company’s model, stating it could be a great investment opportunity for those in need of its technology. In the first quarter of 2025, ARS Pharmaceuticals reported $8.0 million in total revenue with a net loss of $33.9 million. The company holds $275.7 million in cash, cash equivalents, and short-term investments as of March 31. While SPRY shows potential, other AI stocks may offer greater upside potential and lower risk.



Read more at Yahoo Finance: Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier”